Product CAS No
Sorafenib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells.
Sorafenib tosylate is approved to treat: Hepatocellular carcinoma (a type of liver cancer) that cannot be removed by surgery. Renal cell carcinoma (a type of kidney cancer) is advanced.